The Refractory Overactive Bladder: Sacral NEuromodulation vs. BoTulinum Toxin Assessment: ROSETTA trial.
about
OnabotulinumtoxinA vs Sacral Neuromodulation on Refractory Urgency Urinary Incontinence in Women: A Randomized Clinical TrialThe Design of a Randomized Trial of Vaginal Surgery for Uterovaginal Prolapse: Vaginal Hysterectomy With Native Tissue Vault Suspension Versus Mesh Hysteropexy Suspension (The Study of Uterine Prolapse Procedures Randomized Trial)Characteristics Associated with Treatment Response and Satisfaction in Women Undergoing OnabotulinumtoxinA and Sacral Neuromodulation for Refractory Urgency Urinary IncontinenceCan we create a valid treatment algorithm for patients with drug resistant overactive bladder (OAB) syndrome or detrusor overactivity (DO)? Results from a think tank (ICI-RS 2015).Urinary Biomarkers in Women with Refractory Urgency Urinary Incontinence Randomized to Sacral Neuromodulation versus OnabotulinumtoxinA Compared to Controls.Conjoint Urological Society of Australia and New Zealand (USANZ) and Urogynaecological Society of Australasia (UGSA) Guidelines on the management of adult non-neurogenic overactive bladder.The cost-effectiveness of sacral nerve stimulation (SNS) for the treatment of idiopathic medically refractory overactive bladder (wet) in the UK.Two-Year Outcomes of Sacral Neuromodulation Versus OnabotulinumtoxinA for Refractory Urgency Urinary Incontinence: A Randomized Trial.Sacral nerve stimulation versus intravesical botulinum toxin injections for medically refractory overactive bladder: A contemporary review of UK treatment from both clinician and patients’ perspectives
P2860
Q33587587-5342D02D-C2A8-4CED-9E52-6A2155308751Q37033826-BEA69FA5-30D3-4B4C-8320-E80CA5DD683BQ38787744-C1532801-C522-42F9-BE72-054AFAB046C9Q38819016-4C73D55D-321C-4300-AE63-CCE171B0D365Q39019524-81FF544B-0C4A-42F8-A6D0-70EEF8B04B09Q40443607-92913EDB-2B7B-4BB3-8F83-811CD6F20C8CQ45908343-9307242D-3758-4EA0-B547-648240644E4CQ51747376-E017785E-7941-4CF1-955A-A845EB257672Q58461187-177F6FF8-F205-434D-84DD-0633F53AA6E2
P2860
The Refractory Overactive Bladder: Sacral NEuromodulation vs. BoTulinum Toxin Assessment: ROSETTA trial.
description
article científic
@ca
article scientifique
@fr
articolo scientifico
@it
artigo científico
@pt
bilimsel makale
@tr
scientific article published on 30 January 2014
@en
vedecký článok
@sk
vetenskaplig artikel
@sv
videnskabelig artikel
@da
vědecký článek
@cs
name
The Refractory Overactive Blad ...... xin Assessment: ROSETTA trial.
@en
The Refractory Overactive Blad ...... xin Assessment: ROSETTA trial.
@nl
type
label
The Refractory Overactive Blad ...... xin Assessment: ROSETTA trial.
@en
The Refractory Overactive Blad ...... xin Assessment: ROSETTA trial.
@nl
prefLabel
The Refractory Overactive Blad ...... xin Assessment: ROSETTA trial.
@en
The Refractory Overactive Blad ...... xin Assessment: ROSETTA trial.
@nl
P2093
P2860
P1476
The Refractory Overactive Blad ...... xin Assessment: ROSETTA trial.
@en
P2093
Cindy L Amundsen
David D Rahn
Dennis Wallace
Heidi S Harvie
Holly E Richter
Kim Kenton
Sandip Vasavada
Shawn Menefee
Susie Meikle
P2860
P304
P356
10.1016/J.CCT.2014.01.009
P407
P577
2014-01-30T00:00:00Z